| NCT ID | NCT04196842 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2019-10-16 |
| Primary Completion | 2026-10-16 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Heart failure * Objective evidence of cardiac abnormality of structure or function (abnormal ECHO) or elevated levels of B-type natriuretic peptide (\>100 pg/ml) * HF stage B-D and class I-IV Exclusion Criteria: * Patients unable to consent * Inability to comply with the protocol and follow-up requirements * Patients unable to use a smartphone * Patients assessed irregularly (less than two visits in one year) * History of HTx * Use of Mechanical circulatory support device (MCSD) * Comorbidities that, according to the PI, have the potential to interfere with the interpretation of the results
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.